Should I stay on 2.5mg Mounjaro longer than four weeks?

Why does Mounjaro start at 2.5mg in the first place?

Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, activating two gut-hormone pathways that influence appetite and how quickly the stomach empties. That mechanism is effective, but it also explains why the gastrointestinal side effects (nausea, loose stools, burping, that early full-after-three-bites feeling) are most noticeable when you first start or step up. The 2.5mg dose exists specifically to let your system adapt before the medicine's appetite-suppressing effect comes through more fully. Think of it less as treatment and more as orientation. The NHS tirzepatide page describes this graduated approach clearly: the licensed schedule moves in 4-week steps through 2.5, 5, 7.5, 10, 12.5 and 15mg, with titration guided by how well each dose is tolerated.

Most people notice the GI effects peak in the first couple of weeks and then ease. But "most people" is not everyone, and if you are still managing noticeable nausea or digestive disruption at week four, that is a reasonable signal to discuss with your prescriber before stepping up.

Should I stay on 2.5mg Mounjaro if side effects are still bothering me?

Side effects at the starter dose do not automatically mean the medicine is wrong for you, they often mean your body needs a little longer. A prescriber may suggest staying at 2.5mg for an additional four weeks if nausea remains disruptive, if you have had a stomach bug or illness during the first month, or if your routine has been disrupted enough that adding a dose increase feels like bad timing. None of that is unusual. What matters is that the decision is made with clinical input, not guessed at. Trying to power through a dose increase when your stomach is still protesting tends to make tolerability worse, not better, and that can lead people to stop treatment altogether, which is the outcome nobody wants. If you are unsure whether your side effects are normal or worth flagging, the frequently asked questions page covers common concerns, and our prescribers are available for aftercare queries seven days a week.

One practical note: some people find storing their pen in the fridge door next to a familiar landmark (the milk, a water jug) makes the weekly routine feel less clinical and easier to stick to. Small habit anchors help compliance, especially in the early weeks when the medicine is not yet producing obvious results.

Is there any point staying on 2.5mg if I am not losing weight yet?

At 2.5mg, weight loss is not the primary goal. The dose is sub-therapeutic for most people, meaning the appetite-suppression effect that drives significant weight reduction typically comes through more clearly at higher doses. If you are four weeks in and have not seen the scales move, that is expected, not a sign the medicine will not work. The large SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average weight reductions of around 20% at 15mg over 72 weeks, but participants reached that outcome through the full titration journey. The early doses are steps on that path. Extending your time at 2.5mg delays, but does not remove, the possibility of reaching higher doses where the clinical evidence is strongest. If after six months at the highest tolerated dose there has been less than 5% weight loss, NICE guidance suggests reviewing whether to continue, but that review point is well beyond the starter phase.

For a fuller picture of what comes after 2.5mg, the page on deciding whether to increase your Mounjaro dose covers the factors prescribers weigh up. And if you are specifically weighing up the step to 5mg, there is dedicated guidance on moving up to 5mg worth reading first.

When does staying on 2.5mg become the wrong call?

If side effects have settled, you feel well, and nothing clinically flags a reason to stay put, remaining at 2.5mg indefinitely is unlikely to serve your long-term goals. The dose ladder exists for good reason: therapeutic benefit scales with dose for most people, and staying at the starting point means leaving most of that benefit on the table. A prescriber will weigh your tolerability history, any relevant health conditions, and how your body has responded before recommending a step up. That is not a box-ticking exercise, it is the clinical assessment that makes private treatment through a GPhC-registered pharmacy like ours meaningfully different from buying something unverified online. For context on what the next step looks like in practice, the page on Mounjaro 5mg sets out what changes at that dose and what to expect. If you are also thinking ahead to the doses that follow, you can read about what to expect from the Mounjaro 10 mg/0.5 ml pen before you get there. If you are weighing up long-term cost alongside clinical decisions, it is worth knowing that Eli Lilly adjusted Mounjaro's UK list price in September 2025, so checking current pricing before your next order makes sense. And if you find yourself plateauing or feeling settled before the halfway point of the titration schedule, the guidance on whether staying on 5mg is the right move for you is worth a read. When you are ready to talk through your situation with a prescriber, checking your eligibility takes a few minutes and costs nothing.